Results 121 to 130 of about 2,056 (145)

Gene therapy advances using canine and feline animal models of inherited retinal degeneration. [PDF]

Eye (Lond)
Petersen-Jones SM, Beckwith-Cohen B.
europepmc   +1 more source

Novel Therapies for Inherited Retinal Dystrophies. [PDF]

J Clin Med
Kay CN.
europepmc   +1 more source

Advancements in Retinitis Pigmentosa: The Path Toward Personalized Treatment and Vision Restoration. [PDF]

Curr Genomics
Komal, Singh L, Ganti SS.
europepmc   +1 more source

Elucidating the genetic landscape of inherited retinal disorders in India. [PDF]

Hum Genomics
Mathias GP, Raj Rajendran K, Selot R, Shetty R, Kumaramanickavel G, Ghosh A, Ghosh A.   +6 more
europepmc   +1 more source

Gene-sized editing for the therapy of genetic diseases. [PDF]

Funct Integr Genomics
Padureanu T, Cocoș R, Matache IM, Bucur O.   +3 more
europepmc   +1 more source

Nonclinical toxicity study duration in AAV gene therapy development: Evidence from industry survey supports adequacy of short-term assessments. [PDF]

Mol Ther Methods Clin Dev
Assaf BT, Edwards D, Berens SJ, Lauritzen B, Pierrot C, Tukov FF, Bertinetti-Lapatki C, Braun M, Schaefer K, Lynch JL.   +9 more
europepmc   +1 more source

Bench to bedside: Bridging the gap. [PDF]

Indian J Ophthalmol
Steel CL, Wirostko BM.
europepmc   +1 more source

Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants. [PDF]

Sci Adv
Scruggs BA, Berger A, Knudsen T, Kopp FN, Hill M, Trncic E, Anderson K, Iezzi R, Marmorstein AD.   +8 more
europepmc   +1 more source

Voretigene Neparvovec (Luxturna) for Biallelic RPE65-Associated Retinal Dystrophy: Systematic Review.

American Journal of Ophthalmology
Sara Kamalizonouzi
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Luxturna e a nova era da terapia gênica na oftalmologia

EOftalmo, 2020
Fernanda Belga Ottoni Porto
exaly